SCHEMBL17992500

SCHEMBL17992500

CCN1C(=O)c2cccc3c(S(=O)(=O)NCC(C)C)ccc1c23

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 14/20 1.00
ALDH1A1 P00352 6/20 0.71
SMN1; SMN2 Q16637 3/20 0.71
PKM P14618 2/20 0.71
KMT2A Q03164 2/20 0.71
MEN1 O00255 1/20 0.71
MAPT P10636 1/20 0.71
KDM4E B2RXH2 5/20 0.67
HPGD P15428 2/20 0.67
TP53 P04637 1/20 0.66
ALOX15 P16050 1/20 0.66
CASP1 P29466 1/20 0.66
CASP7 P55210 1/20 0.66
HSD17B10 Q99714 1/20 0.66
HTT P42858 1/20 0.65
RORC P51449 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29437266 1.00 BRD4 (1.00) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL17992497 0.88 BRD4 (1.00) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL29437293 0.86 BRD4 (1.00) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL19764638 0.86 BRD4 (1.00) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL17992491 0.84 BRD4 (0.80) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL29437320 0.84 BRD4 (0.80) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL17992507 0.84 BRD4 (1.00) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL29437273 0.84 BRD4 (0.71) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL28454633 0.84 BRD4 (0.71) BRD4ALDH1A1SMN1; SMN2PKMKMT2A
SCHEMBL19764634 0.83 BRD4 (0.81) BRD4ALDH1A1SMN1; SMN2PKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111662226-B 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound 中国科学院广州生物医药与健康研究院 2022-03-18 CN claimed
CN-105985282-B 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound and application thereof 中国科学院广州生物医药与健康研究院 2020-12-08 CN claimed
CN-111662226-A 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound 中国科学院广州生物医药与健康研究院 2020-09-15 CN claimed
CN-111662226-B 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound 中国科学院广州生物医药与健康研究院 2022-03-18 CN disclosed
CN-105985282-B 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound and application thereof 中国科学院广州生物医药与健康研究院 2020-12-08 CN disclosed
CN-111662226-A 2-oxo-1, 2-dihydrobenzo [ cd ] indole compound 中国科学院广州生物医药与健康研究院 2020-09-15 CN disclosed
US-10183010-B2 2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH, CHINESE ACADEMY OF SCIENCES (CN) 2019-01-22 US disclosed
US-20180008574-A1 2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH, CHINESE ACADEMY OF SCIENCES (CN) 2018-01-11 US disclosed
WO-2016119690-A1 2-OXO-1,2-DIHYDROBENZO[CD]INDOLE COMPOUND AND USE THEREOF 中国科学院广州生物医药与健康研究院 2016-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180008574-A1 2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof BRD4, BRD3, BRD1 BRD4 1/4885ALDH1A1 3416/4885SMN1; SMN2 3124/4885
US-10183010-B2 2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof BRD4, BRD3, BRD1 BRD4 1/4885ALDH1A1 3416/4885SMN1; SMN2 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.